SaniSure, founded in 1992, is a United States-based leader in the Biotechnology and Manufacturing industries, specializing in Single Use Technologies (SUT). Known for their "Solution Based Innovation" slogan, the company excels in providing expertise and support for complex flow paths and closed systems design, specifically catering to bioprocessing and advanced therapies workflows.
SaniSure stands out with its diversified and vertically integrated portfolio, offering proprietary solutions, custom assemblies, and engineered components. Utilizing deep product and application expertise, they deliver consultative services to tackle challenging flow path needs. Their leading-edge design and manufacturing capabilities further solidify their position in the market.
Despite the absence of recent investments, SaniSure combines the flexibility of smaller firms with the comprehensive capabilities of larger corporations, making them an attractive prospect for investors seeking innovation and growth in the biotechnology sector.